Adage Capital Partners Gp, L.L.C. Insmed Inc Transaction History
Adage Capital Partners Gp, L.L.C.
- $54.9 Billion
- Q4 2024
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Insmed Inc stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 1,647,562 shares of INSM stock, worth $120 Million. This represents 0.21% of its overall portfolio holdings.
Number of Shares
1,647,562
Previous 1,032,562
59.56%
Holding current value
$120 Million
Previous $75.4 Million
50.9%
% of portfolio
0.21%
Previous 0.14%
Shares
14 transactions
Others Institutions Holding INSM
# of Institutions
498Shares Held
189MCall Options Held
3.21MPut Options Held
2.72M-
Vanguard Group Inc Valley Forge, PA18.2MShares$1.33 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY14.3MShares$1.04 Billion0.02% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y913MShares$947 Million84.75% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.7MShares$928 Million0.1% of portfolio
-
Capital International Investors Los Angeles, CA7.12MShares$520 Million0.1% of portfolio
About INSMED Inc
- Ticker INSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,476,992
- Market Cap $9.9B
- Description
- Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...